Found, the leading evidence-based weight care platform, announced that Luca Ranaldi has been appointed Chief Executive Officer and will join the Found Board of Directors, effective July 22, 2024. Since its founding in 2019, Found has served more than 250,000 patients across the United States, offering personalized, medication-assisted weight loss designed by the industry’s leading obesity specialists.
Luca Ranaldi is a high-impact executive who has scaled companies across healthcare, e-commerce, and tech-enabled services that meet emerging consumer demands. As one of the first employees and former Chief Commercial Officer at Spring Health—a comprehensive mental health solution for employers and health plans—Ranaldi understands the complexities of reducing stigma in areas of our healthcare system that have been overlooked for too long. At Spring Health, Ranaldi helped build the brand to unicorn status, working with members, health plans, and employers alike—experience that aligns with Found’s commitment to work with the healthcare system to forge the future of obesity care with a consumer-first mindset.
“Found is creating a new playbook for comprehensive weight care that consumers actually want to use. Obesity medicine is at a critical inflection point with unprecedented consumer demand, but limited options for accessible, evidence-based care,” said Found CEO, Luca Ranaldi. “Every day, Found delivers best-in-class clinical outcomes by combining the widest range of medications, the support of obesity-specialized providers, and a comprehensive program that applies the highest standards of care in this space. While GLP-1s are getting widespread attention in the market, effective, sustainable obesity care goes far beyond one class of medication. I am thrilled to join Found as we continue to accelerate and deliver on our mission of making weight care accessible for everyone who needs it.”
Also Read: ICF Selected for $88 Million Agreement to Support CMS Digital Modernization Work
On the expertise Ranaldi brings to Found and why it matters for the industry, Board Member Dena Bravata, MD, MS, and co-founder of Lyra Health, said: “Employers experienced a nearly 10% increase in pharmacy benefit costs last year in large part due to growing consumer demand for GLP-1s. They need a trusted partner who understands how to treat obesity with a wide range of evidence-based tools. Found delivers a solution that’s both clinically effective for members and cost effective for employers, and Luca’s experience will allow Found to further expand its reach with employers and health plans to help them best navigate this critical moment for obesity medicine.”
Excess weight and obesity are heterogeneous, multifactorial diseases that impact 70% of Americans, yet only 1% of physicians are certified by the American Board of Obesity Medicine (ABOM). Found recognized this gap long before GLP-1s took over the cultural zeitgeist when it launched in 2019 as a way to make evidence-based obesity medicine more accessible. Today, Found is one of the largest medically-assisted weight loss programs in the U.S., helping its members achieve lasting, sustainable results with specialized care while feeling seen and heard.
SOURCE: Businesswire